ARCHIVES

ASCO Highlights Six Studies From Meeting To Showcase Advances In Cancer Care

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

Cancer Program Depend On Vitality Of Centers, Broder ells DCPC Board

May 12, 1989

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

PET Better At Evaluating Response In Sarcoma

February 29, 2008

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986